Key result
Andexanet alfa effectively reverses factor Xa inhibitors in patients with intracranial hemorrhage.
Why the study?
Does andexanet alfa effectively reverse factor Xa inhibitors in patients that develop intracranial hemorrhage?
Does andexanet alfa effectively reverse factor Xa inhibitors in patients that develop intracranial hemorrhage?
Andexanet alfa is an effective reversal agent for factor Xa inhibitors in patients with intracranial hemorrhage.
Answers are grounded in this paper and cite their sources.
May support andexanet alfa reversal in factor Xa inhibitor ICH; leaves open need for randomized confirmation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Joseph Friedli (2019) studied this question. Andexanet alfa is an effective reversal agent for factor Xa inhibitors in patients developing intracranial hemorrhage.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: